Perrigo | PRGO - Interest Expense On Debt


Perrigo reported $10.08B in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
AbbVie USD 740M 40M Jun/2025
Abbott USD 42M 2M Dec/2025
Bayer EUR 762M 267M Sep/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Coherus Biosciences USD 2.15M 3.2M Mar/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
J&J USD 18M 290M Sep/2025
Merck USD 412M 85M Dec/2025
Nestle CHF 929M 11M Jun/2025
Pacira USD 4.28M 456K Sep/2025
Perrigo USD 10.08B 10.04B Sep/2025
Pfizer USD 711M 59M Dec/2025
Phibro Animal Health USD 8.76M 2.76M Sep/2024
Prestige Brands USD 10.67M 636K Dec/2025
Reckitt Benckiser GBP 208M 198.3M Dec/2024
Sanofi EUR -25M 252M Dec/2025
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Teva Pharmaceutical Industries USD 220M 17M Dec/2025
Xeris Pharmaceuticals USD 7.27M 92K Sep/2025
Zoetis USD 57M 1000K Dec/2025